Related Experiment Video
Updated: May 8, 2026

Bacterial Peptide Display for the Selection of Novel Biotinylating Enzymes
Published on: October 3, 2019
The structure of XIAP BIR2: understanding the selectivity of the BIR domains
Christine Lukacs1, Charles Belunis, Robert Crowther
1Discovery Technologies, Hoffmann-La Roche, 340 Kingsland Street, Nutley, NJ 07110, USA.
Abstract:
XIAP, a member of the inhibitor of apoptosis family of proteins, is a critical regulator of apoptosis. Inhibition of the BIR domain-caspase interaction is a promising approach towards treating cancer. Previous work has been directed towards inhibiting the BIR3-caspase-9 interaction, which blocks the intrinsic apoptotic pathway; selectively inhibiting the BIR2-caspase-3 interaction would also block the extrinsic pathway. The BIR2 domain of XIAP has successfully been crystallized; peptides and small-molecule inhibitors can be soaked into these crystals, which diffract to high resolution. Here, the BIR2 apo crystal structure and the structures of five BIR2-tetrapeptide complexes are described. The structural flexibility observed on comparing these structures, along with a comparison with XIAP BIR3, affords an understanding of the structural elements that drive selectivity between BIR2 and BIR3 and which can be used to design BIR2-selective inhibitors.
Insights
This study details the crystal structures of XIAP BIR2 domain complexes, revealing insights into designing selective inhibitors for cancer therapy by targeting apoptosis pathways.
Area of Science:
- Structural biology
- Molecular mechanisms of apoptosis
- Drug discovery for cancer
Background:
- The inhibitor of apoptosis protein (XIAP) is crucial in regulating apoptosis.
- Targeting XIAP's BIR domains offers a strategy for cancer treatment by modulating apoptosis.
- Selective inhibition of XIAP BIR2-caspase-3 interaction could block the extrinsic apoptotic pathway.
Purpose of the Study:
- To elucidate the structural basis for selective inhibition of the XIAP BIR2 domain.
- To understand the structural elements driving selectivity between XIAP BIR2 and BIR3 domains.
- To guide the design of novel BIR2-selective inhibitors for cancer therapy.
Main Methods:
- Crystallization of the XIAP BIR2 apo domain.
- Soaking peptides and small molecules into BIR2 crystals.
- High-resolution X-ray diffraction analysis.
- Comparative structural analysis of BIR2 apo and complex structures with XIAP BIR3.
Main Results:
- The crystal structure of the XIAP BIR2 apo domain was determined.
- Structures of five BIR2-tetrapeptide complexes were solved.
- Structural flexibility within BIR2 was observed and analyzed.
- Key structural differences between BIR2 and BIR3 were identified, explaining selectivity.
Conclusions:
- Understanding XIAP BIR2 structural flexibility and its differences from BIR3 is key to designing selective inhibitors.
- These findings provide a foundation for developing targeted cancer therapies by inhibiting the extrinsic apoptotic pathway.
- The study offers a rational design strategy for BIR2-selective small-molecule inhibitors.
Related Concept Videos
Benzene to 1,4-Cyclohexadiene: Birch Reduction Mechanism
Regioselectivity and Stereochemistry of Hydroboration
Hydroboration proceeds in a concerted fashion with the attack of borane on the π bond, giving a cyclic four-centered transition state. The –BH2 group is bonded to the less substituted carbon and –H to the more substituted carbon. The concerted nature requires the simultaneous addition of –H and –BH2 across the same face of the alkene giving syn stereochemistry.
Electrophilic 1,2- and 1,4-Addition of X2 to 1,3-Butadiene
Prochirality
Regioselectivity of Electrophilic Additions-Peroxide Effect
Valence Bond Theory

